Molecule Details
| InChIKey | SVOHWMZXBFVEHY-DQDWUXFNSA-N |
|---|---|
| Compound Name | 2-[2-(2-{4-[7-(3-{1-[1-(1-Methoxycarbonyl-2-methyl-propylcarbamoyl)-3-methyl-butylcarbamoyl]-2-methyl-propylcarbamoyl}-propoxy)-naphthalen-2-yloxy]-butyrylamino}-3-methyl-butyrylamino)-4-methyl-pentanoylamino]-3-methyl-butyric acid methyl ester; Dihydrate |
| Canonical SMILES | COC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCCOc1ccc2ccc(OCCCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)OC)C(C)C)C(C)C)cc2c1)C(C)C)C(C)C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.25 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P04585 | gag-pol | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) | Pathogen | PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 | 6.2 | Ki | BindingDB |
| Q72874 | pol | Human immunodeficiency virus type 1 | Pathogen | PF00077 | 6.2 | Ki | ChEMBL |
| Q9YQ12 | protease | Human immunodeficiency virus type 1 | Pathogen | PF00077 | 6.2 | Ki | ChEMBL;BindingDB |